NCT00408954View on ClinicalTrials.gov

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Prostatic Hyperplasia
Interventions
DRUG

UK-369,003

100 mg MR tablet once daily for 2 weeks

DRUG

UK-369,003

UK-369,003-100 mg MR formulation for 2 weeks

Trial Locations (11)

612 00

Pfizer Investigational Site, Brno

500 02

Pfizer Investigational Site, Hradec Králové

775 20

Pfizer Investigational Site, Olomouc

401 13

Pfizer Investigational Site, Ústí nad Labem

1081 HV

Pfizer Investigational Site, Amsterdam

6525 GA

Pfizer Investigational Site, Nijmegen

833 05

Pfizer Investigational Site, Bratislava

036 59

Pfizer Investigational Site, Martin

911 01

Pfizer Investigational Site, Trenčín

040 11

Pfizer Investigational Site, Košice

041 90

Pfizer Investigational Site, Košice

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY